X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Molecular Neurodegeneration

期刊標題檢索 MOL NEURODEGENE 最新評論: How is your progress going? (2024-02-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Molecular Neurodegeneration]您好,您是該頁面的第 54037 位訪客。

期刊簡介
期刊名稱Molecular Neurodegeneration Molecular Neurodegeneration
LetPub Score
8.7
50 ratings
Rate

Reputation
9.5

Influence
8.0

Speed
9.4

期刊簡稱MOL NEURODEGENER
ISSN1750-1326
h-index66
CiteScore
CiteScoreSJRSNIPCiteScore Rank
23.005.2052.566
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Neurology (clinical)
Q16 / 400
Category: Medicine
Subcategory: Cellular and Molecular Neuroscience
Q13 / 97
Category: Medicine
Subcategory: Molecular Biology
Q115 / 410

自引率 (2023-2024)2.70%自引率趨勢
掲載範囲
Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.
官方網站http://molecularneurodegeneration.biomedcentral.com
在線稿件提交https://www.editorialmanager.com/mond
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2006
每年文章數78每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2390; USD2990; EUR2790; )
APC waiver:Check Notes
Other charges: No
Keywords: neurodegenerative diseases、prion diseases、dementia、ageing
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ18/310
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-1326%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Molecular Neurodegeneration】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS NEUROSCIENCEH-index: 357

    CiteScore: 35.00
    NATURE NEUROSCIENCEH-index: 375

    CiteScore: 38.60
    NeuronH-index: 430

    CiteScore: 24.50
    TRENDS IN NEUROSCIENCESH-index: 269

    CiteScore: 26.50
    Annual Review of NeuroscienceH-index: 224

    CiteScore: 25.30
    Journal of NeuroinflammationH-index: 92

    CiteScore: 15.90
    PROGRESS IN NEUROBIOLOGYH-index: 212

    CiteScore: 12.80
    NeurotherapeuticsH-index: 100

    CiteScore: 11.00
    GLIAH-index: 148

    CiteScore: 13.10
    NEUROPSYCHOLOGY REVIEWH-index: 80

    CiteScore: 11.00
    學科內最受檢索的期刊 頁面查看次數
    Journal of Neuroinflammation196855
    NEUROSCIENCE189912
    JOURNAL OF NEUROSCIENCE185805
    BRAIN RESEARCH140176
    MOLECULAR NEUROBIOLOGY129327
    Neuron121663
    NEUROSCIENCE LETTERS115229
    CNS Neuroscience & Therapeutics110054
    NATURE NEUROSCIENCE98385
    CEREBRAL CORTEX98064
  •  

    Molecular Neurodegeneration Molecular Neurodegeneration
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Molecular Neurodegeneration] 的評論撰寫評論
作者: 终幕晓露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-13 12:52:18 評論於
How is your progress going?
(0) 讚! | 终幕晓露

作者: 碧桃运锋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-03 10:03:34 評論於
How long has the editor been assigned?
(0) 讚! | 碧桃运锋

作者: 碧桃运锋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-01 17:58:42 評論於
I would like to ask how long it usually takes for an editor to be assigned before it reaches the editor's hands
(0) 讚! | 碧桃运锋

作者: 黑山泽恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-26 10:15:12 評論於
Research focus: Neuroscience 
Sharing experience: Slow, 6-12 weeks
(0) 讚! | 黑山泽恩

作者: 京城彦会


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-03 21:11:51 評論於
Editorial speed: 12.0 | Submission acceptance rate: 75.0
Experience sharing: The journal's quality is low, and it is all about connections. The editor assigned did not send the submission for review for two months, and then rejected it
(0) 讚! | 京城彦会

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:56:28 評論於
Please delete unnecessary parts based on the main content of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:04:19 評論於
Present the research results in the order of research questions and hypotheses, or alternatively according to the order of research methods. Using chronological order, arranging by importance, or categorizing by different themes are effective methods. When deciding on the structure of presenting research results, one must consider the audience, the basis, and most importantly, the research objectives
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 19:00:25 評論於
What kind of logical order should be followed in the process of organizing the results?
(0) 讚! | Darlene Pepys

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:59:31 評論於
I have too many results, the article cannot contain them all, what should I do?
(0) 讚! | 八坂篷蔚

作者: 雾都淼淼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-01 18:23:24 評論於
Review speed: 2.0 | Submission acceptance rate: 5.0
Experience sharing: The review process is strict, with 5 reviewers. If one disagrees, it will be rejected
(0) 讚! | 雾都淼淼

作者: 四象惜玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-14 21:38:26 評論於
Review Speed: 6.0 | Submission Match Rate: 75.0
Experiences Shared: editor assigned
(0) 讚! | 四象惜玉

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Molecular Neurodegeneration] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*